Most people never think about what happens after a doctor's visit ends. A claim gets filed. An insurer pushes back. Somewhere, a team of people spends days on hold, resubmitting paperwork, fighting for payment that was earned weeks ago. That gap is where Jerry Tubbs and Adonis have decided to work.
Jerry Tubbs is listed in business records as a Chief Executive Officer connected to Adonis, a company built around a single unglamorous idea: healthcare providers should not lose the revenue they have already earned. Adonis calls itself an AI orchestration platform for revenue cycle management, or RCM, the sprawling set of steps that moves a hospital from delivering care to actually being paid for it. It is the plumbing of American medicine, and it leaks.
The pitch starts with a number that unsettles hospital finance chiefs. Providers can lose 15% or more of their potential revenue to inefficiencies in that process, according to figures Adonis cites in its own materials. Claims get denied. Payments come in short. Follow-up work piles up faster than staff can clear it. The company's argument is that this is not a people problem you can hire your way out of, but a workflow problem software can take on directly.
The work right now
What Adonis is building today is a step beyond dashboards. The company describes an evolution from a monitoring and observability tool, one that diagnosed where a revenue cycle was breaking down, into what it calls an agentic layer. In plainer terms: software that does not just flag a problem and wait for a human to act, but takes the next step on its own. AI agents that detect an issue with a payer, recommend the best response, and then carry out the resolution.
That distinction matters in a crowded market. Plenty of vendors automate one narrow slice of billing. Adonis positions itself as the data layer underneath, surfacing the highest-priority problems across the whole cycle and acting on them end to end, from spotting the root cause to closing it out. The goal is a revenue operation that runs quietly in the background and gets a claim paid the first time, rather than the fourth.
The best AI in healthcare may be the kind no patient ever notices. A claim clears. A denial never happens. The plumbing simply works. - On the Adonis thesis, drawn from the company's public positioning
Why the numbers got attention
In March 2026, Adonis announced a $40 million Series C round led by Quadrille Capital, with continued backing from General Catalyst and Bling Capital. The raise pushed the company's total funding past $93 million since it was founded in 2022. Behind the headline number were the metrics investors tend to actually study: more than 4x revenue growth in 2025 and net revenue retention above 130%, a sign that existing customers were not just staying but spending more.
A partner at Quadrille framed the appeal around complexity, noting that the platform tackles the most tangled workflows end to end, from identifying a root cause through to resolution. The subtext is that the boring, back-office corner of healthcare is where a lot of durable value is hiding, precisely because nobody wants to touch it.
Who is actually buying
The names attached to Adonis in its public communications are not fringe clinics. The company has referenced work touching large health systems, including Mount Sinai Health System, and has featured institutions such as Ohio State University's Wexner Medical Center, Yale New Haven Health, and Johns Hopkins Medicine in its materials. One customer, William Vanderveer, chief executive of Redefine Healthcare, described a shift in operations after adopting the platform: real-time intelligence and automation that let his team get ahead of payer challenges, cut denials, and speed up cash flow.
Since adopting Adonis, we've seen a significant transformation in our revenue cycle operations. The platform's capabilities have enabled us to proactively address payer challenges, reduce denials, and accelerate cash flow. - William Vanderveer, CEO, Redefine Healthcare (Adonis customer)
The person behind the title
Public detail on Jerry Tubbs the individual is thinner than the company he is tied to. Records place him in Fort Worth, Texas, and list a chief executive role. His education traces back to Prairie View A&M University, one of Texas's historically Black universities, with study there around 1998 to 2001. Beyond that, the verifiable trail is short, and this profile does not fill the gaps with guesswork.
It is worth being precise about the ambiguity. Adonis the healthcare RCM company was founded in 2022 by brothers Akash and Aman Magoon, who serve as its chief executive and chief product officer. Jerry Tubbs surfaces in contact databases with the Adonis name and a CEO title attached, a common artifact of the way business records get stitched together. What is solid is the mission those records circle: revenue recovery for healthcare providers through intelligent automation.
Where this is heading
The larger story Adonis is riding is the move of agentic AI out of the demo stage and into real operations. The company argues that revenue cycle is a near-ideal proving ground: high volume, rule-heavy, repetitive, and expensive when it goes wrong. If AI agents can reliably work a denied claim to resolution, they can be trusted with a widening set of tasks that once required a room full of specialists on the phone.
There is a workforce angle underneath all of it. RCM teams across the country are short-staffed, and the shortage is structural rather than temporary. The Adonis argument is that automation is not about cutting people so much as covering ground that will otherwise go uncovered, the follow-up that never gets made, the underpayment nobody had time to catch. Measured against that backdrop, the aspiration is straightforward: fewer dollars lost between care delivered and care paid for.
None of this is flashy. There is no consumer app, no viral moment, no product a patient will ever open. The work sits in the machinery that keeps hospitals solvent, and the ambition is to make that machinery smart enough to run itself. For a company operating out of White Plains, New York, and a leadership question that runs through Fort Worth, Texas, that quiet frontier is the whole point.
The next test is durability. Revenue growth and retention numbers look strong on a press release, but agentic AI in a regulated, high-stakes environment has to earn trust one resolved claim at a time. If Adonis clears that bar, it will have turned one of healthcare's most avoided back-office chores into a template for what autonomous software can responsibly own.